ALAlberto Lanzini

Alberto Lanzini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alberto Lanzini has a total of 87 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 10 March 2016
      • Vol. 58  (2) , 115-20

    Subclinical cardiac involvement in Crohn's disease and ulcerative colitis: an echocardiographic case-control study.

    by Enrico Vizzardi, Edoardo Sciatti, Ivano Bonadei, Tania Bordonali, Chiara Ricci, Francesco Lanzarotto, Alberto Lanzini, Marco Metra

    Cardiovascular manifestations of inflammatory bowel disease (IBD) are considered rare. The aim of the present study was to assess cardiac structure and function by means of traditional Doppler echocardiography and tissue Doppler imaging in order to better appreciate myocardial subclinical alterations and their future implications for these kind of patients. Twenty-seven patients affected by Crohn's disease (CD) and 43 suffering from ulcerative colitis (UC) were enrolled. They were selected without cardiovascular diseases nor risk factors. They were compared with 24 healthy subjects matched for sex and age. Everyone underwent transthoracic echocardiography. IBD patients had larger left atrial anterior-posterior dimension (34±7 vs. 31±2 mm; P=0.001) and volume (46±7 vs. 41±6; P=0.002), reduced left ventricular (LV) ejection fraction (59±6 vs. 63±5%; P=0.006) and higher pulmonary artery systolic pressure (26±6 vs. 22±2 mmHg; P<0.001) than healthy volunteers. Moreover, LV diastolic function was slightly altered in patients in respect of controls. Atrioventricular valve regurgitation was prevalent in IBD. Finally, we found that 18 (25.7%) patients had mitral valve prolapse, 35 (50.0%) mitral valve leaflets thickening and 3 (4.3%) pericardial effusion. We did not find differences in echocardiographic parameters between CD and UC. Our study suggests that subclinical cardiac involvement is frequent among IBD patients. The underlying mechanisms require further evaluation, but might be due to a systemic increase in cytokines and profibrotic factors.


  • Factors That Contribute to Hypertransaminasemia in Patients With Celiac Disease or Functional Gastrointestinal Syndromes

    by Barbara Zanini, Roberta Baschè, Alice Ferraresi, Marie Graciella Pigozzi, Chiara Ricci, Francesco Lanzarotto, Vincenzo Villanacci, Alberto Lanzini


  • Open Access

    Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease

    by Barbara Zanini, Beatrice Petroboni, Tarcisio Not, Nicola Di Toro, Vincenzo Villanacci, Francesco Lanzarotto, Norberto Pogna, Chiara Ricci, Alberto Lanzini

    Background: Cereals of baking quality with absent or reduced toxicity are actively sought as alternative therapy to a gluten-free diet (GFD) for patients with coeliac disease (CD). Triticum monococcum, an ancient wheat, is a potential candidate having no toxicity in in-vitro and ex-vivo studies. The aim of our study was to investigate on the safety of administration of a single dose of gluten of Tm in patients with CD on GFD. Methods: We performed a single blind, cross-over study involving 12 CD patients who had been on a GFD for at least 12 months, challenged on day 0, 14 and 28 with a single fixed dose of 2.5 grams of the following (random order): Tm, rice (as reference atoxic protein) and Amygluten (as reference toxic protein) dispersed in a gluten-free pudding. The primary end-point of the study was the change in intestinal permeability, as assessed by changes in the urinary lactulose/rhamnose ratio (L/R ratio) measured by High Pressure Liquid Chromatography. We also assessed the occurrence of adverse gastrointestinal events, graded for intensity and duration according to the WHO scale. Variables were expressed as mean ± SD; paired t-test and χ2 test were used as appropriate. Results: The urinary L/R ratio did not change significantly upon challenge with the 3 cereals, and was 0.055 ± 0.026 for Tm Vs 0.058 ± 0.035 for rice (p = 0.6736) and Vs 0.063 ± 0.054 with Amygluten (p = 0.6071). Adverse gastrointestinal events were 8 for Tm, Vs 11 for rice (p = 0.6321) and Vs 31 for Amygluten p = 0.0016), and, in all cases events were graded as “mild” or “moderate” with TM and rice, and as “severe” or “disabling” in 4 cases during Amygluten. Conclusions: No definite conclusion can be drawn on the safety of Tm, based on no change in urinary L/R because even Amygluten, a toxic wheat protein, did not cause a significant change in urinary L/R indicating low sensitivity of this methodology in studies on acute toxicity. Tm was, however, well tolerated by all patients providing the rationale for further investigation on the safety of this cereal for CD patients. Trial registration: EudraCT-AIFA n2008-000697-20


  • Su1062 Dietary Regimen of Patients With Inflammatory Bowel Disease (IBD)

    by Chiara Ricci, Francesco Lanzarotto, Barbara Zanini, Irene Bresadola, Alberto Lanzini

  • Addicts with chronic hepatitis C: Difficult to reach, manage or treat?

    by Barbara Zanini, Federica Benini, Marie Graciella Pigozzi, Patrizia Furba, Ernesto Giacò, Antonia Cinquegrana, Mariagrazia Fasoli, Alberto Lanzini

    To assess the acceptance, safety and efficacy of care and treatment for chronic hepatitis C (CHC) in drug addicts. We designed a multidisciplinary, phase IV prospective cohort study. All illicit drug users (IDUs) visited a Territorial Addiction Service (SerT) in the District of Brescia, and hepatitis C antibody (HCVAb) testing positive were offered as part of a standardised hepatologic visit in our Gastroenterology Unit. Patients with confirmed CHC and without medical contraindications were administered peginterferon alfa-2b 1.5 μg/kg per week plus ribavirin (800-1400 mg/d) for 16-48 wk. All IDUs were unselected because of ongoing addiction and read and signed an informed consent form. Virologic responses at weeks 4 and 12 of therapy, at the end of treatment and 24 wk after the end of treatment were the main measures of efficacy. Adherence was estimated according to the 80/80/80 criteria. From November 2007 to December 2009, 162 HCVAb+ IDUs were identified. Sixty-seven patients (41% of the initial cohort) completed the diagnostic procedure, and CHC was diagnosed in 54 (33% of the total). Forty-nine patients were offered therapy, and 39 agreed (80% of acceptance rate). The prevalent HCV genotype was type 1, and the HCV RNA baseline level was over 5.6 log/mL in 61% of cases. Five patients dropped out, two because of severe adverse events (SAEs) and three without medical need. Twenty-three and 14 patients achieved end of treatment responses (ETRs; 59%) and sustained virologic responses (SVRs; 36%), respectively. Thirty-one patients were fully compliant with the study protocol (80% adherence). The prevalence of host and viral characteristics negatively affecting the treatment response was high: age over 40 years (54%), male gender (85%), overweight body type (36%), previous unsuccessful antiviral therapy (21%), HCV genotype and viral load (60% and 62%, respectively), earlier contact with HBV (40%) and steatosis and fibrosis (44% and 17%, respectively). In a univariate analysis, alcohol intake was associated with a non-response (P = 0.0018, 95%CI: 0.0058-0.4565). Drug addicts with CHC can be successfully treated in a multidisciplinary setting using standard antiviral combination therapy, despite several "difficult to reach, manage and treat" characteristics.


  • Celiac Disease in Elderly Adults: Clinical, Serological, and Histological Characteristics and the Effect of a Gluten‐Free Diet

    by Silvia Casella, Barbara Zanini, Francesco Lanzarotto, Vincenzo Villanacci, Chiara Ricci, Alberto Lanzini

    Objectives: To compare celiac disease ( CD ) in older and younger adults and to assess the effects of a gluten‐free diet ( GFD ). Design: Retrospective retrieval of information prospectively entered into a structured database. Setting: CD clinic, U niversity and S pedali C ivili, B rescia, I taly. Participants: Two cohorts were identified (older, Group A , n = 59, >65; younger, Group B , n = 1,166, 18–64), and Group B was subgrouped ( B 1, n = 600, 18–34; B 2, n = 440, 35–49; and B 3, n = 26, 50–64). Measurements: Clinical, serological, and histological characteristics of individuals with CD studied before and during a GFD . Results: At presentation, weight loss (37% vs 21%, P = .005) and dyspepsia (22% vs 12%, P = .04) were more frequent in older than younger participants. Incidence at diagnosis of non‐ H odgkin's lymphoma ( NHL ) was much higher in older (5%) than younger participants (0.3%, P = .003). Prevalence of osteoporosis was 67% in older and 14% in younger male participants and 70% in older and 9% in younger female participants ( P < .001). During treatment, adherence to a GFD was 90%, normal villous structure was reconstituted, and t‐transglutaminase antibodies were negative in 80% of older and younger participants. Lumbar‐sacral and femoral T scores increased significantly during a GFD in pooled results of 48 older and younger participants studied before and during GFD . Conclusion: NHL is already present at CD diagnosis in most cases in individuals aged 50 and older, emphasizing the importance of early diagnosis. Older and younger individuals are equally adherent and equally benefit from a GFD , indicating that older age is not a barrier to dietary treatment.


  • Sa1322 Clinical, Serological and Histological Effect of Daily Administration of Triticum Monocccum in Celiac Patients on Gluten Free Diet

    by Barbara Zanini, Alice Ferraresi, Francesco Lanzarotto, Chiara Ricci, Vincenzo Villanacci, Alberto Lanzini

  • Slow gallbladder emptying reverts to normal but small intestinal transit of a physiological meal remains slow in celiac patients during gluten‐free diet

    by F. Benini, A. Mora, D. Turini, S. Bertolazzi, F. Lanzarotto, C. Ricci, V. Villanacci, G. Barbara, V. Stanghellini, A. Lanzini

    Background  Alterations of small intestinal transit and gallbladder (GB) motility have been reported in celiac disease (CD) in studies involving, in most cases, non‐physiological experimental conditions and artificial stimuli to motility. Our aims were to quantitate non‐invasively small intestinal transit time and GB emptying during administration of a physiological and palatable solid meal, and to assess the effect of gluten‐free diet (GFD).Methods  We simultaneously measured mouth‐to‐cecum transit time (MCTT) using a validated H2 breath test, and GB motility using ultrasonography. We studied CD patients before (n = 19) and during (n = 14) GFD, and healthy volunteers (n = 24) following administration of a physiological solid meal (Kcal 539).Key Results  Mouth‐to‐cecum transit time was more prolonged in CD (mean ± SEM: 235 ± 96 min) than in controls (169 ± 65 min, P = 0.0039). The GB fasting volume and postprandial residual volume were significantly higher in CD than in controls, and GB emptying constant was slower in CD than in controls. During GFD, GB emptying reverted to normal, but MCTT remained unchanged (229 ± 69 min) and more prolonged in CD than in controls (P = 0.0139). During GFD, duodenal infiltration with lymphocytes and mast cells persisted higher than that in controls, and the number of mast cells lying in proximity of nervous endings did not change.Conclusions & Inferences  Slow postprandial MCTT in response to a physiological meal does not revert to normal during GFD, an effect mirroring incomplete histopathologic recovery.